Add this topic to your myFT Digest for news straight to your inbox
Deputy PM says government will examine new curbs around technology sharing and call in vice-chancellors
Research harnesses power of generative artificial intelligence in latest sign of its potential use in medicine
Study results could encourage US Medicare system and private insurers to cover tirzepatide treatments
Compounds produced by the technology challenge our idea of novelty
Trillions of cicadas are set to emerge after years of sleep for a once in 221-year occasion
His pioneering theoretical work helped us understand what made the universe possible
Lisa Kaltenegger is an enthusiastic guide to the search for life beyond our planet — and the new technologies that could help it succeed
Also in this newsletter: Bernanke’s Bank of England verdict, the next generational conflict, science round-up
Nobel Prize winner saw his work confirmed by experiments at the Cern particle accelerator
Celestial event offers spectacular views at time of peak alignment between Moon and Sun
UK research highlights risk of over-diagnosis and gaps in spotting serious variants of the disease
The idea that the technology might accelerate general human capabilities remains fanciful
Growing number of countries are also considering whether to amend legislation
Also in this newsletter: house prices fall across Europe, the next pandemic, science round-up
Ex-Tinder CEO Renate Nyborg thinks advanced AI can help
Research forecasts global deaths from the disease will almost double in 20 years
It aims to exploit its extraordinary cache of genetic data but changing corporate DNA is hard
WHO member states are struggling to agree the terms of the first global treaty to deal with the threat of another Covid-19
Patients who took Sanofi’s lixisenatide experienced no worsening of motor symptoms
People (and fish) need to consume this seafood rather than wiping out stocks of the ‘big five’
A new study shows the twisting backstory of an animal touted as a new superfood
UK backs top physicist who supports €16bn expansion plan to probe the Higgs boson
Novo Nordisk and Eli Lilly, plus a clutch of rivals, aim to cut side effects while treating obesity-linked diseases
British AI pioneer says the billions of dollars being poured into start-ups is obscuring scientific progress in the field
Not only is the cost-benefit ratio unbeatable, but not to undertake this spending is to court disaster
International Edition